Hao Q - Search Results

1

Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.

Zhao Z, Shuang T, Gao Y, Lu F, Zhang J, He W, Qu L, Chen B, Hao Q. Zhao Z, et al. Among authors: hao q. Cancer Lett. 2022 Apr 1;530:45-58. doi: 10.1016/j.canlet.2022.01.011. Epub 2022 Jan 18. Cancer Lett. 2022. PMID: 35051533

2

Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer.

Li J, Jiang K, Qiu X, Li M, Hao Q, Wei L, Zhang W, Chen B, Xin X. Li J, et al. Among authors: hao q. BMB Rep. 2014 Jan;47(1):33-8. doi: 10.5483/bmbrep.2014.47.1.069. BMB Rep. 2014. PMID: 24209634 Free PMC article.

3

Effects of FSTL1 on cell proliferation in breast cancer cell line MDA‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.

An J, Wang L, Zhao Y, Hao Q, Zhang Y, Zhang J, Yang C, Liu L, Wang W, Fang D, Lu T, Gao Y. An J, et al. Among authors: hao q. Oncol Rep. 2017 Nov;38(5):3001-3010. doi: 10.3892/or.2017.6004. Epub 2017 Sep 26. Oncol Rep. 2017. PMID: 29048681 Free PMC article.

4

Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy.

Du J, Wan Z, Wang C, Lu F, Wei M, Wang D, Hao Q. Du J, et al. Among authors: hao q. Theranostics. 2021 Jul 13;11(17):8185-8196. doi: 10.7150/thno.59121. eCollection 2021. Theranostics. 2021. PMID: 34373736 Free PMC article.

5

LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214-5p-JAG1 axis.

Pan L, Du M, Liu H, Cheng B, Zhu M, Jia B, Wang Y, He W, Li X, Liu C, Gu J, Li M, Zhang Y, Yao L, Zhang Y, Hao Q. Pan L, et al. Among authors: hao q. Ann Transl Med. 2021 Sep;9(17):1369. doi: 10.21037/atm-21-2755. Ann Transl Med. 2021. PMID: 34733921 Free PMC article.

6

CD63⁺ cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to breast cancer cells by exosomal miR-20.

Sun J, Du R, Li X, Liu C, Wang D, He X, Li G, Zhang K, Wang S, Hao Q, Zhang Y, Li M, Gao Y, Zhang C. Sun J, et al. Among authors: hao q. Cancer Lett. 2024 Apr 28;588:216747. doi: 10.1016/j.canlet.2024.216747. Epub 2024 Feb 23. Cancer Lett. 2024. PMID: 38403110 Free article.

7

High-yield expression, purification and characterization of tumor-targeted IFN-alpha2a.

Meng J, Yan Z, Wu J, Li L, Xue X, Li M, Li W, Hao Q, Wan Y, Qin X, Zhang C, You Y, Han W, Zhang Y. Meng J, et al. Among authors: hao q. Cytotherapy. 2007;9(1):60-8. doi: 10.1080/14653240601094322. Cytotherapy. 2007. PMID: 17354103

8

Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients.

Li M, Xu T, Zhang Z, Xue X, Zhang C, Qin X, Li W, Hao Q, Zhang W, Zhang Y. Li M, et al. Among authors: hao q. Cancer Sci. 2012 Feb;103(2):288-95. doi: 10.1111/j.1349-7006.2011.02153.x. Epub 2012 Jan 9. Cancer Sci. 2012. PMID: 22085427 Free article. Clinical Trial.

9

Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development.

Hao Q, Lu X, Liu N, Xue X, Li M, Zhang C, Qin X, Li W, Shu Z, Song B, Wang Q, Song L, Zhang W, Zhang Y. Hao Q, et al. BMB Rep. 2013 Jun;46(6):316-21. doi: 10.5483/bmbrep.2013.46.6.208. BMB Rep. 2013. PMID: 23790975 Free PMC article.

10

Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.

Li W, Ran Y, Li M, Zhang K, Qin X, Xue X, Zhang C, Hao Q, Zhang W, Zhang Y. Li W, et al. Among authors: hao q. BMC Biotechnol. 2013 Sep 27;13:77. doi: 10.1186/1472-6750-13-77. BMC Biotechnol. 2013. PMID: 24073737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,381 results

Search Page

Filters